Macquarie analyst David Bailey ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Intl Ratings

CLSA Downgrades ResMed (RMD:AU) (RMD) to Outperform (2), 'High near-term expectations may detract from long-term tailwinds'August 15, 2022 6:31 AM